ProVee System
Benign Prostatic Hyperplasia (BPH) / Lower Urinary Tract Symptoms (LUTS)
Pivotal Trial CompletedActive
Key Facts
Indication
Benign Prostatic Hyperplasia (BPH) / Lower Urinary Tract Symptoms (LUTS)
Phase
Pivotal Trial Completed
Status
Active
Company
About ProVerum Medical
ProVerum Medical is a private, venture-backed medical device startup developing the ProVee System, a first-line interventional therapy for BPH. The company's core innovation is a universally sized, 3D-geometry nitinol stent that engages the prostate's anatomy to provide rapid, reversible relief of urinary obstruction. With pivotal clinical studies completed in the US, Canada, and Ireland, ProVerum is positioning its atraumatic, retrieval-friendly device as a potential paradigm shift in the early interventional treatment of BPH, targeting a massive and growing global market dominated by drug therapies and more invasive surgical options.
View full company profile